Sebastian BioPharma
PrivateLast Round
Accelerator
Jun 1, 2025
Total Funding Raised
$8.53M
Company Overview
Sebastian BioPharma operates in Healthcare & Life Sciences and is based in Beverly, Massachusetts. Its latest recorded funding round was an Accelerator round in June 2025.
Sebastian BioPharma is a biotechnology company that develops tumor-targeted, multi-pathway therapeutics for immunotherapy-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sebastian BioPharma Comparables
Compare Sebastian BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tallac Therapeutics | 73% | |
| Gilead Sciences | 69% | |
| Replicate Bioscience | 67% |
For institutional investors. Book with your work email.
Sebastian BioPharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sebastian BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders Fund | Angel |
| SCbioDrive | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Received funding from SCbioDrive.
For institutional investors. Book with your work email.
Sebastian BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sebastian BioPharma's valuation, stock price, and market status.
Is Sebastian BioPharma a public or private company?
Sebastian BioPharma is a private company.
What is the current stock price of Sebastian BioPharma?
Sebastian BioPharma is a private company, so its shares have no public market price. Caplight tracks Sebastian BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sebastian BioPharma worth (valuation)?
Valuation information for Sebastian BioPharma is not publicly available.
Can I buy Sebastian BioPharma stock?
Sebastian BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sebastian BioPharma's last funding round?
Sebastian BioPharma's most recent funding round was Accelerator on June 1, 2025.
Who are the main investors in Sebastian BioPharma?
Key investors in Sebastian BioPharma include Founders Fund, SCbioDrive.
Will Sebastian BioPharma IPO soon?
No public IPO plans have been announced for Sebastian BioPharma.
How can I track Sebastian BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in Sebastian BioPharma's shares on secondary markets.